JNJ

We're picking up more shares of an out-of-favor stock with a bright future

We are buying 50 shares of Johnson & Johnson at roughly $221.43. Following the trade, Jim Cramer's Charitable Trust will own 340 shares of JNJ, increasing its weighting to 1.9% from 1.62%. We're picking up shares of J & J here and lowering our average cost basis as healthcare and drug stocks move lower on Monday.